GlassScriptPhysician profile
Philip T Britton
NPI 1780691436
$10,156.50
in general payments reported to CMS, 2019-2025
32 companies · $2,097 in 2025
The $2,097 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,807 · 2022: $1,476 · 2023: $1,317 · 2024: $3,460 · 2025: $2,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,604 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,020 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,604.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,020.00 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $1,872.67 | 2022-2025 | Opzelura |
| Abbvie INC. | $1,349.29 | 2021-2025 | |
| Genzyme Corporation | $1,021.30 | 2021-2025 | |
| Janssen Biotech, INC. | $776.13 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Regeneron Healthcare Solutions, INC. | $695.08 | 2021-2025 | Dupixent, Libtayo |
| Medimetriks Pharmaceuticals, INC. | $500.00 | 2021-2024 | Neo-Synalar, Genadur |
| Ucb, INC. | $444.32 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $418.80 | 2021-2025 | |
| Dermavant Sciences, INC. | $405.74 | 2022-2024 | Vtama |
| Lnhc, INC | $328.04 | 2025 | Zelsuvmi |
| Arcutis Biotherapeutics, INC. | $304.05 | 2023-2025 | Zoryve |
| Leo Pharma INC. | $287.18 | 2021-2025 | Adbry, Anzupgo |
| Galderma Laboratories, L.P. | $242.45 | 2021-2025 | Aklief, Nemluvio, Twyneo |
| Sun Pharmaceutical Industries INC. | $229.51 | 2021-2025 | Ilumya |
| Novartis Pharmaceuticals Corporation | $202.87 | 2021-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $167.24 | 2021-2025 | Ebglyss, Taltz |
| Amgen INC. | $146.90 | 2021-2025 | Otezla |
| Almirall LLC | $136.63 | 2021-2025 | Seysara, Klisyri |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $100.87 | 2021-2023 | Jublia, Arazlo, Duobrii |
| Mayne Pharma Commercial LLC | $73.77 | 2021-2025 | |
| Vyne Pharmaceuticals INC. | $66.54 | 2021 | |
| Organon LLC | $56.65 | 2025 | Vtama |
| Botanix Sb INC | $53.64 | 2025 | Sofdra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.52 | 2023-2024 | Spevigo |
| E.R. Squibb & Sons, L.L.C. | $48.52 | 2023-2024 | Sotyktu |
| Epi Health, LLC | $47.51 | 2021-2022 | |
| Nabriva Therapeutics, Plc | $33.47 | 2021 | |
| Verrica Pharmaceuticals INC. | $33.01 | 2023 | Ycanth |
| Paratek Pharmaceuticals, INC. | $20.72 | 2022 | |
| Merz North America, INC. | $17.17 | 2023 | |
| Strata Skin Sciences, INC. | $15.11 | 2025 | Xtrac |
| Genentech USA, INC. | $7.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Britton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.